Compare BCC & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCC | SRPT |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2013 | 1997 |
| Metric | BCC | SRPT |
|---|---|---|
| Price | $88.36 | $17.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 28 |
| Target Price | ★ $101.83 | $25.76 |
| AVG Volume (30 Days) | 368.6K | ★ 3.0M |
| Earning Date | 02-20-2026 | 02-25-2026 |
| Dividend Yield | ★ 0.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.07 | N/A |
| Revenue | ★ $6,511,894,000.00 | $2,413,715,000.00 |
| Revenue This Year | N/A | $14.46 |
| Revenue Next Year | $3.27 | N/A |
| P/E Ratio | $17.80 | ★ N/A |
| Revenue Growth | N/A | ★ 47.15 |
| 52 Week Low | $65.14 | $10.42 |
| 52 Week High | $126.96 | $120.05 |
| Indicator | BCC | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 65.53 | 31.41 |
| Support Level | $80.62 | $19.62 |
| Resistance Level | $83.12 | $21.36 |
| Average True Range (ATR) | 2.74 | 1.37 |
| MACD | 0.29 | -0.43 |
| Stochastic Oscillator | 79.62 | 0.13 |
Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two reportable segments, namely Wood Products and Building Materials Distribution. The Wood Products segment manufactures laminated veneer lumber (LVL), I-joists, and laminated beams. In addition, it manufactures structural, appearance, and industrial-grade plywood panels, and ponderosa pine lumber. The Building Materials Distribution segment is engaged in the distribution of various building materials, including oriented strand board (OSB), plywood, and lumber; general line items such as siding, composite decking, doors and millwork, metal products, roofing, and insulation; and EWP, among others. The company generates a majority of its revenue from the Building Material Distribution segment.
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.